User is not a member of any group.
There are currently 0 users online.
...
Pfizer executives said the commercial pricing for adult doses could start early next year, depending on when the government phases out its program of buying and distributing the shots.
"It's going to be very hard to manage our health-care system if we don't make some important changes," Jha said.
The COVID-19 booster market is starting to look more like an annual flu season than it did in the first two years of the pandemic.
Recent Comments